학술논문
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies
Document Type
article
Author
Source
Nature Communications, Vol 13, Iss 1, Pp 1-6 (2022)
Subject
Language
English
ISSN
2041-1723
Abstract
SARS-CoV-2 vaccination has shown reduced efficacy in patients with haematological malignancies. Here, the authors show that a third vaccine is able to enhance SARS-CoV-2 antibody responses in most cases in a cohort of 381 patients with haematological malignancies.